Aging
Why cells grow old, and what senescence research means for treating disease.
Notes on aging
Rapamycin, metformin and the race to slow aging
Two old drugs have become the benchmarks for anti-aging research. Here is why, and why caution still matters.
Altos Labs and the $3 billion bet on rejuvenation
A new company launched with $3 billion to pursue cellular rejuvenation. It says a lot about where aging research is heading.
Aducanumab’s approval and the cost of rushing hope
The first new Alzheimer’s drug in nearly 20 years was approved amid serious doubts about whether it works.
First human trial of senolytics: promising, and very early
A small pilot study tested drugs that clear senescent cells in patients with a fatal lung disease.
From willow bark to aspirin, and back again
The plant that gave us aspirin turned out to have more to say about aging than anyone expected.
Why yeast is the best aging model you’ve never heard of
The same organism that makes bread and beer has quietly shaped what we know about how cells work, and how they age.
A Nobel Prize for autophagy, and a win for yeast research
Yoshinori Ohsumi’s Nobel Prize recognizes how cells recycle themselves. He discovered it in yeast.